SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001437749-16-039880
Filing Date
2016-10-18
Accepted
2016-10-18 06:38:13
Documents
4
Period of Report
2016-10-18
Items
Item 7.01: Regulation FD Disclosure
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K kmph20161017_8k.htm 8-K 33421
2 EXHIBIT 99.1 ex99-1.htm EX-99.1 32798
3 acura.jpg GRAPHIC 11578
4 ex99-1img001.jpg GRAPHIC 6450
  Complete submission text file 0001437749-16-039880.txt   92493
Mailing Address 2500 CROSSPARK ROAD, SUITE E126 CORALVILLE IA 52241
Business Address 2500 CROSSPARK ROAD, SUITE E126 CORALVILLE IA 52241 319-665-2575
KEMPHARM, INC (Filer) CIK: 0001434647 (see all company filings)

IRS No.: 205894398 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36913 | Film No.: 161939805
SIC: 2834 Pharmaceutical Preparations